Literature DB >> 9136907

Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver.

H L Schieferdecker1, E Rothermel, A Timmermann, O Götze, K Jungermann.   

Abstract

Anaphylatoxins (C5a and C3a), which are generated during complement activation, have recently been shown to increase glucose output from hepatocytes (HC) in perfused rat liver. They did not act directly on HC but indirectly by prostanoid release from non-parenchymal cells (NPC), probably Kupffer cells (KC). In order to corroborate this mechanism, the distribution of anaphylatoxin receptors in the different cell types of rat liver was determined by quantitative RT-PCR with primers specific for the rat C5a receptor (rC5aR) using RNA isolated from KC, sinusoidal endothelial cells (SEC), hepatic stellate cells (HSC) and HC. In line with functional data, C5aR mRNA was detected in freshly isolated NPC but not in HC of rat liver. Mainly KC but also HSC clearly expressed C5aR mRNA, while SEC did so only weakly. KC expressed up to 10-fold more C5aR mRNA than HSC and these in turn up to 10-fold more than SEC. These results support the proposed indirect action of anaphylatoxins on HC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9136907     DOI: 10.1016/s0014-5793(97)00292-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells.

Authors:  A Fayyazi; O Scheel; T Werfel; S Schweyer; M Oppermann; O Götze; H J Radzun; J Zwirner
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 2.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

3.  Rat complement factor I: molecular cloning, sequencing and expression in tissues and isolated cells.

Authors:  G Schlaf; E Rothermel; M Oppermann; H L Schieferdecker; K Jungermann; O Götze
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

4.  Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.

Authors:  A J Short; N J Paczkowski; S M Vogen; S D Sanderson; S M Taylor
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

5.  Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit.

Authors:  D R Bachvarov; S Houle; M Bachvarova; J Bouthillier; S A St-Pierre; Y Fukuoka; J A Ember; F Marceau
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 6.  Nuanced roles of cytokines in three major human brain disorders.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

7.  Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.

Authors:  Lei Sun; Ren-Feng Guo; Hongwei Gao; J Vidya Sarma; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2009-07-20       Impact factor: 5.191

8.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

9.  New insights for C5a and C5a receptors in sepsis.

Authors:  Chunguang Yan; Hongwei Gao
Journal:  Front Immunol       Date:  2012-12-10       Impact factor: 7.561

10.  Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure.

Authors:  Shihui Sun; Yan Guo; Guangyu Zhao; Xiaojun Zhou; Junfeng Li; Jingya Hu; Hong Yu; Yu Chen; Hongbin Song; Fei Qiao; Guilian Xu; Fei Yang; Yuzhang Wu; Stephen Tomlinson; Zhongping Duan; Yusen Zhou
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.